Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Prevalence and concentrations of serum T3, T4, TSH, IL-6 and IL-10 in the evaluated non-thyroidal illness subgroups of patients.

From: Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency

VARIABLES MI (n = 20) CHF (n = 20) CRI (n = 20)
T3 (n mol/L) 0.63 ± 0.13 (70%) 1.07 ± 0.47 (35%) 1.14 ± 0.57 (40%)
T4 (n mol/L) 75.65 ± 37.57 (70%) 70.85 ± 22.68 (25%) 78.2 ± 23.47 (45%)
TSH (μIU/L) 1.23 ± 0.63 (72%) 0.96 ± 0.32 (18%) 1.04 ± 0.54 (26%)
IL-6 (ng/L) 192.55 ± 15.12 82.95 ± 18.90 40.50 ± 14.38
IL-10 (ng/L) 122.95 ± 46.06 69.05 ± 44.04 30.4 ± 10.57
  1. Values in parentheses represent the percentages of patients with lower than normal concentrations of the corresponding parameter.
  2. MI = myocardial infarction, CHF=congestive heart failure and CRI =chronic renal insufficiency.